# Continuous Cellsaver and Neurocognitive Decline Post Cardiac Surgery

> **NCT00296985** · PHASE4 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 312 (—)

## Conditions studied

- Heart Disease
- Neurocognitive Decline

## Interventions

- **DEVICE:** Fresenius Cellsaver

## Key facts

- **NCT ID:** NCT00296985
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-12
- **Primary completion:** 2005-01
- **Final completion:** 2007-01
- **Target enrollment:** 312 (—)
- **Last updated:** 2013-11-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00296985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00296985, "Continuous Cellsaver and Neurocognitive Decline Post Cardiac Surgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00296985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*